iShares Health Innovation Active ETF Rating $25.19 +0.10 (+0.40%) (As of 11:17 AM ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatings iShares Health Innovation Active ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.74Holdings in BMED have an aggregate rating of Moderate Buy based on 760 analyst ratings issued in the past year covering 44 companies (67.1% of the portfolio).BMED Aggregate Price Target$25.19High Prediction$25.19Average Prediction$25.19Low Prediction$25.19Holdings in BMED have an aggregate price target of $25.19 and a range of $25.19 to $25.19 covering 44 companies (67.1% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.94%ISRGIntuitive Surgical$550.19+1.5%4.6567 of 5 stars2.68$524.61 -4.6%19Analyst UpgradePositive News4.53%BSXBoston Scientific$91.50+1.5%4.6133 of 5 stars2.91$93.39 2.1%23Analyst Forecast3.25%ARGXargenx$590.27-0.3%2.8331 of 5 stars2.91$630.42 6.8%23Analyst Forecast3.05%GILDGilead Sciences$89.66+1.2%4.658 of 5 stars2.65$94.45 5.3%26Analyst UpgradePositive News2.22%ABTAbbott Laboratories$117.17+1.1%4.971 of 5 stars2.75$130.07 11.0%16Positive News2.15%DHRDanaher$234.00+0.4%4.9362 of 5 stars2.74$287.16 22.7%19Analyst DowngradePositive News2.04%TECHBio-Techne$70.98+3.3%4.8609 of 5 stars2.67$81.78 15.2%91.97%RGENRepligen$140.00+0.8%4.6306 of 5 stars2.73$190.25 35.9%111.89%SRPTSarepta Therapeutics$110.64-0.2%4.9391 of 5 stars3.00$181.33 63.9%22Analyst Downgrade1.87%WATWaters$367.47+2.7%4.1559 of 5 stars2.27$365.85 -0.4%151.75%PODDInsulet$263.45-1.2%4.4109 of 5 stars2.80$253.27 -3.9%15Positive News1.72%ALNYAlnylam Pharmaceuticals$246.44-0.9%4.4125 of 5 stars2.71$298.09 21.0%24Analyst Forecast1.64%MDTMedtronic$84.64+0.6%4.9601 of 5 stars2.44$95.19 12.5%18Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.45%EXASExact Sciences$53.39+1.3%4.8884 of 5 stars2.95$74.47 39.5%19Analyst ForecastPositive News1.45%NTRANatera$169.52+1.0%2.8143 of 5 stars3.00$140.59 -17.1%17Analyst Forecast1.42%WSTWest Pharmaceutical Services$318.77+2.3%4.9681 of 5 stars2.67$460.33 44.4%3Analyst Revision1.41%TMOThermo Fisher Scientific$515.28+0.5%4.9906 of 5 stars2.86$649.33 26.0%22Buyback AnnouncementPositive News1.40%BMYBristol-Myers Squibb$58.42+0.9%4.7863 of 5 stars2.20$54.07 -7.4%20Analyst Revision1.39%NBIXNeurocrine Biosciences$124.89+1.3%4.955 of 5 stars2.83$163.91 31.2%24Positive News1.37%SNYSanofi$47.95+0.4%2.8245 of 5 stars2.75$57.50 19.9%4Analyst Revision1.35%RYTMRhythm Pharmaceuticals$59.40+0.1%3.3053 of 5 stars2.90$62.30 4.9%10Analyst Forecast1.34%PFEPfizer$24.95+0.0%5 of 5 stars2.50$32.92 32.0%16Analyst DowngradeAnalyst RevisionNews Coverage1.31%ABBVAbbVie$172.07+2.6%4.9638 of 5 stars2.90$203.37 18.2%21Analyst ForecastPositive News1.29%BGNEBeiGene$193.42-0.4%3.1938 of 5 stars2.71$247.07 27.7%7Analyst Downgrade1.16%AMGNAmgen$290.04+0.8%4.9108 of 5 stars2.46$333.57 15.0%26Ex-DividendShort Interest ↓Positive News1.06%INSMInsmed$73.71+1.4%4.0926 of 5 stars3.00$83.07 12.7%16Positive News1.06%XENEXenon Pharmaceuticals$40.01+1.7%3.5315 of 5 stars3.08$57.45 43.6%12Analyst Revision1.05%DNLIDenali Therapeutics$24.32-0.4%4.4921 of 5 stars2.73$38.90 60.0%111.02%VRTXVertex Pharmaceuticals$450.35-0.2%4.0563 of 5 stars2.53$499.12 10.8%30Analyst DowngradeNews CoveragePositive News1.00%EWEdwards Lifesciences$70.51+1.4%4.1404 of 5 stars2.38$75.67 7.3%26Short Interest ↓Analyst Revision0.99%MRUSMerus$45.06+5.0%3.0132 of 5 stars3.14$85.45 89.6%14Analyst ForecastNews CoverageGap Up0.96%UTHRUnited Therapeutics$368.39+1.1%4.5228 of 5 stars2.73$370.86 0.7%15Analyst RevisionPositive News0.94%EXELExelixis$34.73+0.2%4.7941 of 5 stars2.65$31.44 -9.5%20Insider Trade0.94%QGENQiagen$42.35+0.6%4.2716 of 5 stars2.60$50.88 20.1%100.93%DXCMDexCom$74.85-0.5%4.9848 of 5 stars2.72$104.59 39.7%18Positive News0.93%AAgilent Technologies$131.80+2.5%3.9673 of 5 stars2.50$144.36 9.5%14Upcoming EarningsNews Coverage0.91%LHLaboratory Co. of America$240.42+1.1%4.786 of 5 stars2.80$255.92 6.4%15Positive News0.90%BIIBBiogen$158.24+1.4%4.8674 of 5 stars2.54$257.20 62.5%28Analyst Downgrade0.89%PENPenumbra$239.68+0.2%4.3239 of 5 stars2.71$227.92 -4.9%14Analyst ForecastInsider Trade0.87%BPMCBlueprint Medicines$97.01+2.3%2.7179 of 5 stars2.71$122.11 25.9%21Analyst ForecastAnalyst Revision0.84%GHGuardant Health$30.61-0.2%4.2981 of 5 stars2.94$40.60 32.6%160.82%HOLXHologic$78.62+0.7%4.8724 of 5 stars2.67$89.91 14.4%120.82%IQVIQVIA$196.42+1.0%4.9855 of 5 stars2.84$256.50 30.6%19Analyst ForecastAnalyst Revision0.80%SYKStryker$390.08+1.1%4.942 of 5 stars2.80$393.65 0.9%20Analyst RevisionPositive News This page (NYSEARCA:BMED) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
